Lyumjev®

Description

Lyumjev® (insulin lispro-aabc)

Lyumjev® is an ultra rapid-acting mealtime insulin designed to help people with diabetes manage blood sugar spikes faster and more effectively around meals.

Formulated with advanced absorption technology, Lyumjev begins working quickly after injection to better match the body’s natural insulin response following food intake. It is used in adults and children with diabetes to improve daily glucose control. (Drugs.com)

Key Benefits

• Ultra rapid-acting insulin for post-meal glucose control
• Helps reduce blood sugar spikes after eating
• Designed for both type 1 and type 2 diabetes
• Can be used with:
  • Insulin pens
  • Syringes
  • Certain insulin pumps
• Available in U-100 and U-200 strengths (Drugs.com)

How It Works

Lyumjev contains insulin lispro-aabc, a fast-acting insulin analog formulated to absorb into the bloodstream more quickly than standard insulin lispro formulations. This allows insulin action to begin sooner during meals, helping improve glycemic control. (Eli Lilly and Company)

Indications

Lyumjev is indicated to improve blood sugar control in:

• Adults with diabetes mellitus
• Pediatric patients with diabetes mellitus (Drugs.com)

Administration

• Injected at the start of a meal or within 20 minutes after beginning a meal
• Administered subcutaneously using:
  • KwikPen®
  • Vials
  • Compatible insulin pumps
• Dosing should be individualized by a healthcare provider (Drugs.com)

Why Choose Lyumjev

Lyumjev offers a modern ultra-fast insulin option designed to better control post-meal blood sugar rises while fitting into flexible daily diabetes management routines. It provides a faster onset profile compared with traditional rapid-acting insulin lispro products. (Eli Lilly and Company)

Important Safety Information

Common side effects may include:

• Low blood sugar (hypoglycemia)
• Injection site reactions
• Weight gain
• Swelling in hands or feet

Serious risks may include severe hypoglycemia and allergic reactions. Blood glucose monitoring and medical supervision are required during treatment. (Drugs.com)